155 related articles for article (PubMed ID: 34882306)
1. p62/SQSTM1 in liver diseases: the usual suspect with multifarious identities.
Tan CT; Soh NJH; Chang HC; Yu VC
FEBS J; 2023 Feb; 290(4):892-912. PubMed ID: 34882306
[TBL] [Abstract][Full Text] [Related]
2. p62/SQSTM1-Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer.
Taniguchi K; Yamachika S; He F; Karin M
FEBS Lett; 2016 Aug; 590(15):2375-97. PubMed ID: 27404485
[TBL] [Abstract][Full Text] [Related]
3. SQSTM1/p62 and Hepatic Mallory-Denk Body Formation in Alcohol-Associated Liver Disease.
Qian H; Ding WX
Am J Pathol; 2023 Oct; 193(10):1415-1426. PubMed ID: 36906265
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinomas with intracellular hyaline bodies have a poor prognosis.
Aigelsreiter A; Neumann J; Pichler M; Halasz J; Zatloukal K; Berghold A; Douschan P; Rainer F; Stauber R; Haybaeck J; Denk H; Lackner C
Liver Int; 2017 Apr; 37(4):600-610. PubMed ID: 27885796
[TBL] [Abstract][Full Text] [Related]
5. Sequestosome 1/p62-related pathways as therapeutic targets in hepatocellular carcinoma.
Denk H; Stumptner C; Abuja PM; Zatloukal K
Expert Opin Ther Targets; 2019 May; 23(5):393-406. PubMed ID: 30987486
[TBL] [Abstract][Full Text] [Related]
6. Vault-phagy: a phase-separation-mediated selective autophagy of vault, a non-membranous organelle.
Kurusu R; Morishita H; Komatsu M
Autophagy; 2024 Feb; 20(2):441-442. PubMed ID: 37815214
[TBL] [Abstract][Full Text] [Related]
7. MOAP-1-mediated dissociation of p62/SQSTM1 bodies releases Keap1 and suppresses Nrf2 signaling.
Tan CT; Chang HC; Zhou Q; Yu C; Fu NY; Sabapathy K; Yu VC
EMBO Rep; 2021 Jan; 22(1):e50854. PubMed ID: 33393215
[TBL] [Abstract][Full Text] [Related]
8. p62/Sequestosome-1 Is Indispensable for Maturation and Stabilization of Mallory-Denk Bodies.
Lahiri P; Schmidt V; Smole C; Kufferath I; Denk H; Strnad P; Rülicke T; Fröhlich LF; Zatloukal K
PLoS One; 2016; 11(8):e0161083. PubMed ID: 27526095
[TBL] [Abstract][Full Text] [Related]
9. Integrated proteomics identifies p62-dependent selective autophagy of the supramolecular vault complex.
Kurusu R; Fujimoto Y; Morishita H; Noshiro D; Takada S; Yamano K; Tanaka H; Arai R; Kageyama S; Funakoshi T; Komatsu-Hirota S; Taka H; Kazuno S; Miura Y; Koike M; Wakai T; Waguri S; Noda NN; Komatsu M
Dev Cell; 2023 Jul; 58(13):1189-1205.e11. PubMed ID: 37192622
[TBL] [Abstract][Full Text] [Related]
10. Cross β-sheet conformation of keratin 8 is a specific feature of Mallory-Denk bodies compared with other hepatocyte inclusions.
Mahajan V; Klingstedt T; Simon R; Nilsson KP; Thueringer A; Kashofer K; Haybaeck J; Denk H; Abuja PM; Zatloukal K
Gastroenterology; 2011 Sep; 141(3):1080-1090.e1-7. PubMed ID: 21699779
[TBL] [Abstract][Full Text] [Related]
11. Levels of metacaspase1 and chaperones related to protein quality control in alcoholic and nonalcoholic steatohepatitis.
Mendoza AS; Dorce J; Peng Y; French BA; Tillman B; Li J; French SW
Exp Mol Pathol; 2015 Feb; 98(1):65-72. PubMed ID: 25526666
[TBL] [Abstract][Full Text] [Related]
12. Role of p62/SQSTM1 in liver physiology and pathogenesis.
Manley S; Williams JA; Ding WX
Exp Biol Med (Maywood); 2013 May; 238(5):525-38. PubMed ID: 23856904
[TBL] [Abstract][Full Text] [Related]
13. Are the Mallory bodies and intracellular hyaline bodies in neoplastic and non-neoplastic hepatocytes related?
Denk H; Stumptner C; Fuchsbichler A; Müller T; Farr G; Müller W; Terracciano L; Zatloukal K
J Pathol; 2006 Apr; 208(5):653-61. PubMed ID: 16477590
[TBL] [Abstract][Full Text] [Related]
14. p62/
Jeong SJ; Zhang X; Rodriguez-Velez A; Evans TD; Razani B
Antioxid Redox Signal; 2019 Aug; 31(6):458-471. PubMed ID: 30588824
[No Abstract] [Full Text] [Related]
15. Hepatocyte-specific TAZ deletion downregulates p62/ Sqstm1 expression in nonalcoholic steatohepatitis.
Yang X; Sheng S; Du X; Su W; Tian J; Zhao X
Biochem Biophys Res Commun; 2021 Jan; 535():60-65. PubMed ID: 33341674
[TBL] [Abstract][Full Text] [Related]
16. The ménage à trois of autophagy, lipid droplets and liver disease.
Filali-Mouncef Y; Hunter C; Roccio F; Zagkou S; Dupont N; Primard C; Proikas-Cezanne T; Reggiori F
Autophagy; 2022 Jan; 18(1):50-72. PubMed ID: 33794741
[TBL] [Abstract][Full Text] [Related]
17. p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming.
Saito T; Ichimura Y; Taguchi K; Suzuki T; Mizushima T; Takagi K; Hirose Y; Nagahashi M; Iso T; Fukutomi T; Ohishi M; Endo K; Uemura T; Nishito Y; Okuda S; Obata M; Kouno T; Imamura R; Tada Y; Obata R; Yasuda D; Takahashi K; Fujimura T; Pi J; Lee MS; Ueno T; Ohe T; Mashino T; Wakai T; Kojima H; Okabe T; Nagano T; Motohashi H; Waguri S; Soga T; Yamamoto M; Tanaka K; Komatsu M
Nat Commun; 2016 Jun; 7():12030. PubMed ID: 27345495
[TBL] [Abstract][Full Text] [Related]
18. Thyroid hormone suppresses hepatocarcinogenesis via DAPK2 and SQSTM1-dependent selective autophagy.
Chi HC; Chen SL; Tsai CY; Chuang WY; Huang YH; Tsai MM; Wu SM; Sun CP; Yeh CT; Lin KH
Autophagy; 2016 Dec; 12(12):2271-2285. PubMed ID: 27653365
[TBL] [Abstract][Full Text] [Related]
19. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis.
Lee DH; Han DH; Nam KT; Park JS; Kim SH; Lee M; Kim G; Min BS; Cha BS; Lee YS; Sung SH; Jeong H; Ji HW; Lee MJ; Lee JS; Lee HY; Chun Y; Kim J; Komatsu M; Lee YH; Bae SH
Free Radic Biol Med; 2016 Oct; 99():520-532. PubMed ID: 27634173
[TBL] [Abstract][Full Text] [Related]
20. From Mallory to Mallory-Denk bodies: what, how and why?
Zatloukal K; French SW; Stumptner C; Strnad P; Harada M; Toivola DM; Cadrin M; Omary MB
Exp Cell Res; 2007 Jun; 313(10):2033-49. PubMed ID: 17531973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
